Patent Notice definition

Patent Notice. To be furnished by Licensor and approved by Licensee in a separate writing signed by the parties;
Patent Notice. The use of O-17-gas for imaging of tissue of a subject in a Proton Magnetic Resonance Imaging System is subject to patents held by Rockland Technimed Ltd., Xxxxxxx Xxxxx, 0 Xxxxxxx Xxxxx, Xxxxxxx, Xxx Xxxx 00000, XXX. For the use of the O-17-gas in medical imaging, supplied according to this offer, the buyer of O-17-gas is potentially liable for infringement of one or more patents held by Rockland Technimed Ltd. without this End user license.
Patent Notice. Mannatech shall xxxx all Licensed Product packaging and advertising comprising beta 1,3/1,6 glucan: "Protected by US patents 5,576,015; 5,519,009; 5,397,773; 5,705,184; and 5,702,719. Other US and Canadian patents pending." ("the Glucan Patents") or otherwise as Lactoferrin may direct by written notice. Mannatech shall xxxx all Licensed Product packaging and advertising not comprising beta 1,3/1,6 glucan: "US and Canadian patents pending." or otherwise as Lactoferrin may direct by written notice. In making such notice, Mannatech relies upon representations of Lactoferrin that the beta 1,3/1,6 glucan used in the Dietary Supplements is covered by the Glucan Patents. If Lactoferrin becomes aware that a product marketed by Mannatech containing colostrum and lactoferrin does not fall within the scope of any Licensed Patent, Lactoferrin will provide notice to Mannatech.

Examples of Patent Notice in a sentence

  • Customer agrees to regularly review the products-to-patent number(s) association at the Patent Notice to check for updates.

  • Some or all associations of the third-party products-to-patents are also identified in the Patent Notice by each associated third-party and product name.

  • The association of products-to-patent numbers in the Patent Notice may not be an exclusive listing of associations, and other unlisted patents or pending patents may also be associated with the Software.

  • In accordance with the time frames set forth in Section 103.4(a), and in response to a Request for Patent Notice issued by GSA, Members should provide GSA with a Written Response solely for purposes of technical evaluation by the applicable GSA committee.

  • See also Federal Trade Commission, The Evolving IP Marketplace: Align­ ing Patent Notice and Remedies With Competition 85 (2011) (quoting testimony that patent system fosters “an incentive to be as vague and ambiguous as you can with your claims” and “defer clarity at all costs”).7 Eliminating that temptation is in order, and “the patent drafter is in the best position to resolve the ambiguity in .

  • Provided that such Written Response is timely submitted and submitted in Good Faith in accordance with this Section 103.3(a), such Written Response may be supplemented by such Member, as desired, until a Request for Patent Notice is issued by GSA in accordance with Section 103.4(b) or 4(c).

  • The parties hereby agree that TSRI shall prepare and file such provisional patent application for the Technology identified by Sponsor in the Patent Notice in accordance with Section 4.4 hereof.

  • The March 2011 FTC report on Aligning Patent Notice and Remedies with Competition [6] says,A patent does not necessarily confer market power because patented inventions often compete with alternative technologies.

  • Gemstar shall then have [*] days to provide Microsoft with written notice if Gemstar concludes that the product or service infringes any of Gemstar's Licensed Patents, which notice (the "Patent Notice") shall specifically identify such Licensed Patents by patent number and claim.

  • Federal Trade Commission, The Evolving IP Marketplace: Aligning Patent Notice and Remedies with Competition 194 (2011).


More Definitions of Patent Notice

Patent Notice. With respect to the IMO® MapIT Software being used, the following patents may apply: United States Patent No(s): 6,904,432; 7,693,917; and additional patents pending.
Patent Notice shall have the meaning as defined in Section 4.3.

Related to Patent Notice

  • infringement notice has the meaning set forth in Section 7.4.1;

  • Patent Application means an application for patent protection for a CRADA Subject Invention with the United States Patent and Trademark Office (“U.S.P.T.O.”) or the corresponding patent-issuing authority of another nation.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or restoration by existing or future extension or restoration mechanisms (including, without limitation, supplementary protection certificates or the equivalent thereof), or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Opt-Out Notice has the meaning specified therefor in Section 2.02(a) of this Agreement.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Publication Notice means the summary notice of proposed Settlement and hearing for publication substantially in the form attached as Exhibit 3 to Exhibit A.

  • Regulatory Exclusivity Period means, with respect to each Licensed Product in any country in the Territory, a period of exclusivity (other than Patent exclusivity) granted or afforded by Applicable Law or by a Regulatory Authority in such country that confers exclusive marketing rights with respect to such Licensed Product in such country or prevents another Person from using or otherwise relying on any data supporting the approval of the Drug Approval Application for such Licensed Product to support an application for regulatory approval of another product for any indication without the prior written consent of the Drug Approval Application holder.

  • Valid Patent Claim means a claim of the Licensed Patents that has not lapsed or become abandoned or been declared invalid or unenforceable by a court or agency of competent jurisdiction from which no appeal can be or is taken.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.

  • Xxxxx Notice means the Notice of Grant of Stock Option accompanying the Agreement, pursuant to which Optionee has been informed of the basic terms of the option evidenced hereby.

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Patent Family means all patents and patent applications that share a common priority application, excluding continuations in part, but including any divisionals, continuations, reissues, reexaminations, extensions, foreign counterparts or equivalents. For the avoidance of doubt, if any patent or patent application is subject to a terminal disclaimer with any other patent or patent application such patent or patent application and such other patent or patent application shall be deemed one (1) Patent Family for the purposes of this Agreement.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • License Period means the period beginning from the Commencement Date and ending on the Termination Date.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • NDA means a New Drug Application, as defined in the regulations promulgated by the United States Food and Drug Administration, or any foreign equivalent thereof.

  • CAFA Notice refers to the notice requirements imposed by 28 U.S.C. § 1715(b).

  • Disagreement Notice has the meaning set forth in Section 2.2.3.1(b).

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Product Patents means any and all United States patents and patent applications, all divisionals, continuations, continuations-in-part, re-issues, extensions or foreign counterparts thereof, now or hereafter owned or controlled ("controlled" being used in the sense of having the right to grant licenses thereunder) by PERIMMUNE, covering the manufacture, use, sale, offer for sale and/or importation of the Product, including but not limited to, the U.S. Patent No. 5,407,912 attached hereto as Exhibit B.

  • FOIA Notice means a decision notice, enforcement notice and/or an information notice;